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INTRODUCTION
Ritodrine hydrochloride (RTH), chemically 1-(4-
hydroxy phenyl)-2-[2-(4-hydroxy phenyl) ethyl amino]
propanol, is a selective 
 
b
 
2
 
-receptor agonist that is used
to control premature labor and reverse fetal distress
caused by excessive uterine activity [1]. Ritodrine is
used widely in obstetrics [2]. In view of the increased
pharmaceutical applications of ritodrine, its assay and
quality control are very important.
The literature reveals that only a few methods con-
cern the determination of RTH in pharmaceutical-dos-
age forms. Spectrophotometric methods based on the
formation of colored dye by the coupling reaction
between the oxidation product of MBTH [3] and 4-ami-
noantipyrine [4] and diazotized 
 
p
 
-nitroaniline and sul-
phanilic acid [5]. Other reactions are based on nitration
with subsequent complex formation [6]. Besides, fluo-
rimetric and spectrophotometric [7] methods have been
reported for the assay of RTH. The current United
States Pharmacopoeia [8] describes an HPLC method
for the analysis of RTH. In biological fluids, RTH has
been determined by the HPLC [9] and GLC [10] meth-
ods. For routine quality control, the development of a
simple, rapid, and reliable method is highly desirable.
The aim of the present work is to develop an HPLC
method for the analysis of RTH in both pure and dosage
forms. This new method is simple, rapid, accurate, and
reliable.
EXPERIMENTAL
 
Apparatus.
 
 We used the HPLC equipment of a Shi-
madzu model class VP 10 series with a Shimadzu tunable
absorbance detector and column of 
 
250
 
 · 
 
4.6
 
 mm i.d.
containing Hypersil Shendon ODS packing material at
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ambient temperature with a chart speed 0.5 cm min
 
–1
 
. The
mobile phase consisted of 0.02 M KH
 
2
 
PO
 
4
 
 + acetonitrile
(75 : 25), and the pH was adjusted to 4.0 with dilute
phosphoric acid at flow rate of 1 ml min
 
–1
 
. A UV detec-
tor at 270 nm was used.
 
Reagents.
 
 Potassium hydrogen orthophosphate
(0.02 M) was prepared by dissolving 1.3609 g of
KH
 
2
 
PO
 
4
 
 (Loba Chemie Pvt. Ltd., India) in 500 mL of
distilled water. HPLC-grade acetonitrile and ortho-
phosphoric acid A.R. were used.
 
Standard solution.
 
 Pure compounds of ritodrine
(RTH) and isoxsuprine hydrochlorides (ISH) were
received from Duphar-Interfran Ltd., India, and were
used as such. The stock solutions of RTH and ISH were
prepared in the mobile phase in a 100-mL standard
flask so as to get a concentration of 1000 
 
m
 
g mL
 
–1
 
.
Solutions with lower concentrations were prepared by
diluting the standard solutions. ISH was used as the
internal standard.
 
Assay procedure.
 
 In a 100-mL calibrated flask, an
accurately weighed amount (from the mixed and pow-
dered contents of twenty tablets) of 50 mg of RTH was
dissolved in 75 mL of the mobile phase and the con-
tents were thoroughly shaken for about 30 min. Then,
the volume was diluted up to the mark with the mobile
phase, mixed well, and filtered using quantitative filter
paper. The requisite amount of the drug solution was
mixed with 10 
 
m
 
g mL
 
–1
 
 of ISH (IS) in a 10-mL cali-
brated flask and diluted to the mark with the mobile
phase. A 50 
 
m
 
L of this solution was injected into the
column. The peak area ratio of RTH was calculated.
The amount of the drug was assayed from the calibra-
tion graph, which was constructed using a standard
solution of RTH.
For the analysis of injection solution, the requisite
volume was transferred to a 100-mL calibrated flask
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Abstract
 
—A simple, rapid, and accurate HPLC method is described for the determination of ritodrine hydro-
chloride (RTH) in both pure form and pharmaceutical formulations. A Hypersil Shendon ODS column with a
mobile phase of dibasic phosphate buffer and acetonitrile (75 : 25) and isoxsuprine hydrochloride were used as
an internal standard. The flow rate was 1 mL min
 
–1
 
 and the effluent was monitored at 270 nm pH 4.0. The cal-
ibration graph is linear in the range 2–30 
 
m
 
g mL
 
–1
 
. The proposed HPLC method has been successfully
employed for the determination of RTH in Yutopar tablets and injection solutions.
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and diluted to the mark with the mobile phase. The drug
content in the diluted solution was assayed as described
above. The results are presented in Table 1.
RESULTS AND DISCUSSION
A Hypersil Shendon reverse phase column is used
for the separation of a large number of organic com-
pounds, including some chemotherapeutic agents. It
was observed that this column gives a satisfactory sep-
aration of RTH and ISH in the solvent system com-
prised of a dibasic phosphate buffer (pH 4) and aceto-
nitrile.
 
Mobile phase. 
 
The composition of the mobile phase
that gave the optimum chromatographic conditions was
investigated. A mobile phase consisting of acetonitrile
and water (50 + 50) adjusted to pH 3 did not give well-
defined sharp peaks for RTH and ISH. The use of a
mobile phase consisting of an acetonitrile–phosphate
buffer (25 + 75) adjusted to pH 6 did not yield the
required separation within a short time (the retention
time of RTH was >8 min). A mobile phase consisting of
a phosphate buffer (0.02 M) and acetonitrile (75 + 25)
adjusted to pH 4.0 with dilute orthophosphoric acid
gave the optimum resolution of RTH and ISH (see fig-
ure). The presence of organic solvent in the mobile
phase resulted in the reduction of the column back-
pressure, shorter retention times, and sharper peaks. No
interference from the other components in the pharma-
ceutical formulations was encountered using this
mobile phase.
The pH of the mobile phase was a critical factor in
obtaining good resolution and sharp peaks. It also influ-
enced the retention times of the two components. The
concentration of the phosphate buffer only influenced
the retention times of the two components: increasing
the concentration to 75 mL reduced the retention time
of RTH to 2.7 min. The use of the mobile phase to dilute
the mixture of the RTH and ISH aliquots to the final
volume before injection into the column was also nec-
essary to achieve the optimum conditions. The reten-
tion times for RTH and ISH were 2.71 and 3.36 min,
respectively. The method was found to be linear in the
concentration range from 2 to 30 
 
m
 
g mL
 
–1
 
 of RTH.
 
Internal standard. 
 
Isoxsuprine hydrochloride was
selected as the internal standard because of its struc-
tural similarity to RTH. It was observed that a good res-
olution was obtained under the operating conditions.
 
Precision and accuracy. 
 
The precision of the pro-
posed method was evaluated by replicate analyses of
samples containing RTH at three different concentra-
tions (low, medium, and high). 
The within-day precision showed a RSD of 0.60 or
0.14% at the low concentration (5 
 
m
 
g mL
 
–1
 
). The
between-day precision evaluated over a period of five
days showed a RSD of 0.61 or 0.10% at the low concen-
tration. The low values of both the within- and
between-day RSDs at the low concentration reflect the
 
Table 1.
 
  Analysis of RTH in pharmaceutical preparations (
 
n
 
 = 5)
Preparation Analyte taken (
 
m
 
g mL
 
–1
 
)
Analyte found 
(
 
m
 
g mL
 
–1
 
)
% Recovery 
 
–
 
 SD
 
t
 
-value*
 
F
 
-value**Officinal 
method
Proposed 
method
Yutopar***, 5
 
5.06 99.9 
 
–
 
 0.4 101.2 
 
–
 
 0.7 2.6 3.06
 
tablet 15
 
14.63 98.0 
 
–
 
 0.9 99.5 
 
–
 
 1.2 2.4 1.77
 
25
 
24.98 101.2 
 
–
 
 0.8 99.9 
 
–
 
 1.0 1.1 1.52
 
Yutopar***,
 
 for
 
5
 
4.99 99.5 
 
–
 
 1.1 99.8 
 
–
 
 1.3 0.6 1.39
 
injection 15
 
15.03 99.9 
 
–
 
 0.4 100.2 
 
–
 
 0.5 1.7 1.56
 
50 mg/10 mL 25
 
24.93 100.5 
 
–
 
 0.5 99.7 
 
–
 
 0.6 2.4 1.44
 
     *Tabulated value, 2.78.
  ** Tabulated value, 6.39.
***Marketed by Duphar Interfran Ltd.
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The HPLC chromatogram. (
 
1) 
 
RTH; (
 
2)
 
 ISH. See text for
explanation.
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high precision of the method. At the high concentration
(25 
 
m
 
g mL
 
–1
 
) both the within- and between-day RSDs
were very low, which further indicates that the method
is highly precise. The results are presented in Table 2.
APPLICATIONS
The developed HPLC method was applied to the
determination of RTH in pharmaceutical formulations.
The experimental results of the assay of RTH in Yutopar
tablets and injections using the proposed HPLC method
compare favorably with the officinal method of United
States Pharmacopoeia [8] and are shown in Table 1.
A statistical analysis of the results by Student’s 
 
t
 
- and
 
F
 
-tests showed no significant difference in the accuracy
and precision between the proposed and officinal meth-
ods (Table 1).
CONCLUSIONS
In conclusion, a specific, rapid, and accurate HPLC
method has been developed to estimate RTH in both
pure and pharmaceutical-dosage forms.
No extra peaks were obtained even when sample
chromatograms were run for longer periods. These
observations suggest that the inactive ingredients or
degradation products are absent. Also, there is no inter-
ference from common excipients like starch, talc, dex-
trose, etc., which are generally present in the formula-
tion. The developed HPLC method can serve as an
alternative to other methods for the determination of
RTH in pharmaceutical formulations.
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Table 2.
 
  Within- (I) and between-day (II) precision of the RTH assay
Preparation
I II
Analyte taken 
(
 
m
 
g mL
 
–1
 
)
Analyte found* 
(
 
m
 
g mL
 
–1
 
) 
 
–
 
 SD RSD, %
Analyte taken 
(
 
m
 
g mL
 
–1
 
)
Analyte found* 
(
 
m
 
g mL
 
–1
 
) 
 
–
 
 SD RSD, %
RTH 5 4.98 
 
–
 
 0.03 0.60 5 4.94 
 
–
 
 0.03 0.61
Pure form 15 14.98 
 
–
 
 0.02 0.17 15 14.91 
 
–
 
 0.02 0.13
25 25.19 
 
–
 
 0.04 0.14 25 25.92 
 
–
 
 0.03 0.10
Yutopar tablet 5 4.97 
 
–
 
 0.02 0.40 5 4.92 
 
–
 
 0.02 0.45
15 14.93 
 
–
 
 0.03 0.20 15 14.98 
 
–
 
 0.01 0.06
25 25.91 
 
–
 
 0.02 0.08 25 25.98 
 
–
 
 0.02 0.08
Yutopar for injection 5 4.96 –  0.03 0.50 5 4.92 –  0.02 0.45
15 14.99 –  0.02 0.40 15 14.98 –  0.01 0.06
25 24.89 –  0.06 0.25 25 24.98 –  0.02 0.08
* Average recovery from five determinations (n = 5).
